REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation
Clinical trial NCT05902533 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05902533
- Sponsor
- University of Cincinnati
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2026-08-14
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.